Revolutionizing telemedicine for patients, providers, and partners alike
2020
Investment2024
ExitRevolutionizing Telemedicine with a White-Label Solution
This consumer healthtech startup developed a white-label, asynchronous telemedicine platform that enabled companies to offer prescription-level care online using board-certified physicians. By eliminating traditional barriers to healthcare access, the platform enabled patients to receive care within hours, while physicians earned up to nine times more than they would through conventional office visits.
For providers, the platform was designed to streamline operations and reduce inefficiencies, addressing challenges such as complex workflows and uneven case distribution. With an intuitive, tech-driven experience, medical professionals could focus on what matters the most - delivering high-quality care to patients.
XRC’s Prescription for Growth
At XRC Ventures, we have long believed in the consumerization of healthcare. Even before the pandemic, we recognized telehealth as a rapidly expanding market and saw the immense potential of this startup’s model.
By investing in and supporting the company’s launch, XRC helped scale the platform’s monthly consultations to over 10,000 - a milestone that positioned the startup as a leader in the space. We also played a key role in enhancing the platform’s technology features, ensuring long-term scalability and sustained value creation.
Results & Impact
Together with XRC Ventures, this consumer healthtech company accomplished:
Over 200%
Over 50x
Over 150%
In 2024, the company was acquired, marking a successful exit for XRC while continuing its trajectory of growth. Post-acquisition, the company has expanded its customer base and service offerings, further solidifying its impact in the healthcare industry.
At XRC Ventures, we don’t just invest - we identify, scale, and drive transformational success in high-growth markets.
